Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weierkang treatment duration study in chronic atrophic gastritis
ChiCTR-IPR-16008996Phase 4Completed
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Mar 2014
- Countries
- 1
01
Overview
Phase 4, open-label trial of weierkang in atrophic gastritis (AG) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Total effective rate. Started Mar 2014; status: completed.
02
Drugs
weierkang
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on ChiCTR-IPR-16008996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008996.